| |||
 | |||
 |
Uva Ursi | ||
| |||
| |||
| |||
|
Dehydroepiandrosterone (DHEA) | ||
|
Vitamin A (Retinol) | ||
|
Vitamin B3 (Niacin) | ||
|
| |||
|
| U.S. Brand Names |
| AK-Trol®; Dexacidin®; Dexasporin®; Maxitrol® |
 |
| Generic Available |
|
Yes |
|
| Synonyms |
| dexamethasone, neomycin, and polymyxin b; polymyxin b, neomycin, and dexamethasone |
|
| Pharmacological Index |
|
Antibiotic/Corticosteroid, Ophthalmic |
|
| Use |
|
Steroid-responsive inflammatory ocular conditions in which a corticosteroid is indicated and where bacterial infection or a risk of bacterial infection exists |
|
| Pregnancy Risk Factor |
|
C |
|
| Adverse Reactions |
|
1% to 10%: Ocular: Cutaneous sensitization, eye pain, development of glaucoma, cataract, increased intraocular pressure, optic nerve damage |
|
| Drug Interactions |
|
No data reported |
|
| Mechanism of Action |
|
Refer to individual monographs |
|
| Pharmacodynamics/Kinetics |
|
Refer to individual monographs |
|
| Usual Dosage |
|
Children and Adults: Ophthalmic: Solution: Instill 1-2 drops into affected eye(s) every 3-4 hours; in severe disease, drops may be used hourly and tapered to discontinuation |
|
| Administration |
|
Tilt head back, place medication in conjunctival sac and close eyes |
|
| Dental Health: Local Anesthetic/Vasoconstrictor Precautions |
|
No information available to require special precautions |
|
| Dental Health: Effects on Dental Treatment |
|
No effects or complications reported |
|
| Patient Information |
|
Notify physician if condition worsens or does not improve in 3-4 days |
|
| Nursing Implications |
|
Shake well before using Monitor intraocular pressure with use >10 days |
|
| Dosage Forms |
|
Ophthalmic: Suspension: Neomycin sulfate 3.5 mg, polymyxin B sulfate 10,000 units and dexamethasone 0.1% per mL (5 mL, 10 mL) |
|
|
Copyright © 2007 Drugs Area |
